Skip to main content
T

Theromics

Theromics develops biocompatible nanopolymer gels, HeatSYNC™ and CryoSYNC, that enhance thermal energy transfer during soft tissue ablation procedures, resulting in larger and more precise ablation zones. This technology addresses the high recurrence rates in soft tissue ablation by improving targeting accuracy and reducing systemic side effects when combined with existing drug therapies.

West Bridgewater, United StatesFounded 201611300+ followers
Updated 20 months ago

Funding

$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

M
Funding rounds are not available yet.

Founders

Product

Problem

Soft tissue ablation procedures often face challenges with recurrence due to inaccurate targeting, heat sinks caused by blood flow, and non-spherical ablation zones. These issues can lead to incomplete treatment and the need for re-intervention.

Solution

Theromics is developing HeatSYNC™ and CryoSYNC, biocompatible nanopolymer gels designed to enhance thermal energy transfer during soft tissue ablation. These gels mitigate heat loss, improve thermal penetration, and facilitate more accurate targeting of tumors. By optimizing the shape and size of the ablation zone, Theromics' technology aims to reduce recurrence rates associated with soft tissue ablation. The gels can also be combined with existing drug therapies for localized treatment, potentially reducing systemic side effects through Thermally Activated Combination Therapy (TACT).

Target Audience

The primary target audience includes medical professionals performing soft tissue ablation procedures, such as interventional radiologists, surgeons, and oncologists.

Features

  • Nanopolymer platform technology designed to address shortcomings of thermal ablation of soft tissue
  • HeatSYNC™ and CryoSYNC gels are IP-protected, biocompatible, and made of human proteins
  • Facilitates energy transfer in human tissue, allowing for larger and more effective soft tissue ablations
  • Mitigates "heat sinks" by absorbing energy and preventing heat loss caused by blood flow
  • Improves thermal penetration, optimizing the shape of the ablation zone into a predictable sphere
  • Compatible with various ablation modalities, including RF, microwave, IRE, Cryoablation, and pulsed electric field (PEF)
  • Can be delivered percutaneously, laparoscopically, or endobronchially
This profile is AI-generated and may contain inaccuracies.